Regular GU Cast guest, Dr Ben Tran, joins us today to review some highlights from the recent virtual #ESMO20 Annual Meeting. Ben made headlines himself at this year's meeting as he presented his phase 1 study of AMG160 was selected for the prostate cancer plenary session (you got to tune in to hear him explain what a half-life extended bi-specific T cell engager is! Peter Mac Phase I and GU Fellow, Dr Ciara Conduit, also joins us to discuss this and other highlights including IPAT, PROfound, and the Checkmate 9ER study for mRCC. Usual hosts Declan Murphy and Renu Eapen.